Mangoceuticals, Inc.
MGRX
$1.73
$0.074.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.20M | -11.18M | -8.71M | -9.33M | -9.13M |
| Total Depreciation and Amortization | 1.97M | 1.17M | 760.80K | 45.30K | 51.30K |
| Total Amortization of Deferred Charges | -222.70K | 0.00 | 0.00 | 464.30K | 222.70K |
| Total Other Non-Cash Items | 6.33M | 3.99M | 2.45M | 2.75M | 2.33M |
| Change in Net Operating Assets | 291.40K | -124.50K | 631.10K | 638.90K | 548.90K |
| Cash from Operations | -5.83M | -6.15M | -4.86M | -5.43M | -5.98M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | 0.00 | 65.00K | 65.00K | 65.00K | 65.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 65.00K | 65.00K | 65.00K | 65.00K |
| Total Debt Issued | 562.50K | 62.50K | 150.00K | 187.50K | 187.50K |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 3.63M | 2.28M | 1.33M | 1.77M | 1.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2.30M | 3.80M | 2.65M | 2.25M | 1.50M |
| Repurchase of Preferred Stock | -1.05M | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.44M | 6.15M | 4.13M | 4.21M | 3.46M |
| Foreign Exchange rate Adjustments | -900.00 | -2.20K | -9.90K | -1.70K | -1.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -389.30K | 61.10K | -680.40K | -1.16M | -2.46M |